Assessing ANI Pharmaceuticals (ANIP) Valuation After a Strong Yearly Share Price Rally [Yahoo! Finance]
ANI Pharmaceuticals, Inc. (ANIP)
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
anipharmaceuticals.com/investors_corporate_profile.php
Company Research
Source: Yahoo! Finance
See our latest analysis for ANI Pharmaceuticals. With the share price now at $80.73, recent weakness, including a negative 90 day share price return, looks more like a breather within a strong multi year total shareholder return trend. This suggests that sentiment is consolidating rather than reversing. If ANI's run has you thinking more broadly about opportunities in the sector, this could be a good moment to explore healthcare stocks for other potential long term compounders. With earnings growing faster than revenue and the stock still trading at a sizeable discount to analyst targets, the key question now is whether ANI remains mispriced value or if the market has already captured its future growth. With ANI Pharmaceuticals closing at $80.73 versus a narrative fair value of $109.88, the current valuation implies a sizable gap that hinges on ambitious growth assumptions. The analysts have a consensus price target of $99.0 for ANI Pharmaceuticals based on their expectatio
Show less
Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIP alerts
High impacting ANI Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANIP
News
- Is ANI Pharmaceuticals Stock Price Justified After 47% 2025 Rally? [Yahoo! Finance]Yahoo! Finance
- How Investors May Respond To ANI Pharmaceuticals (ANIP) Creating a Retina-Focused FutureVision Advisory Council [Yahoo! Finance]Yahoo! Finance
- Implied Volatility Surging for ANI Pharmaceuticals Stock Options [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals (NASDAQ:ANIP) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $100.00 price target on the stock.MarketBeat
- ANI Pharmaceuticals Announces Formation of “FutureVision Advisory Council” to Help Strategically Guide Ophthalmology and Retina FranchiseGlobeNewswire
ANIP
Earnings
- 11/7/25 - Beat
ANIP
Sec Filings
- 12/19/25 - Form 4
- 12/12/25 - Form 4
- 12/9/25 - Form 4
- ANIP's page on the SEC website